The diagnostics industry is playing an influential role in healthcare’s shift toward prevention and personalized care. Emerging diagnostics companies are tasked to find a sustainable competitive edge in a challenging market. The diagnostics industry is itself transforming through innovative technologies and a broadening role across the patient journey—from early detection to continuous monitoring and personalized treatment regimens.


The ongoing industry transformation presents emerging players with tremendous opportunities and a plethora of challenges. A business intelligence and analytics program can play a central role in helping organizations turn these challenges into opportunities in the following ways:

  • Pairing primary and secondary data analytics maximizes the impact of limited resources by estimating market potential, identifying the target population and guiding marketing strategies.
  • Equipping the field team with advanced data insights guides strategic targeting and drives more meaningful engagements.
  • Investing in the right digital and marketing content promotes awareness and adoption.
  • Collaborating with patients and providers yields real-world evidence related to improved patient outcomes data.

In this white paper we’ll discuss the importance of a structured business intelligence and analytics program for long-term success as well as provide the building blocks to ensure it is comprehensive and facilitates all functional groups within the organization.